Related Experiment Video
Updated: May 3, 2026
05:14
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
4.2K
Schizophrenia: from dopaminergic to glutamatergic interventions
1New Medicines Neurosciences Therapeutic Area Head, UCB Pharma, S.A., Belgium.
Current Opinion in Pharmacology
|February 15, 2014
Summary
Schizophrenia may stem from neurodevelopmental issues. This review highlights the interconnected roles of dopamine and glutamate imbalances, particularly N-methyl aspartate (NMDA) receptor hypofunction, in the complex etiology of schizophrenia.
Area of Science:
- Neuroscience
- Psychiatry
- Neurodevelopmental disorders
Background:
- Schizophrenia is increasingly viewed as a neurodevelopmental disorder.
- The precise underlying mechanisms of schizophrenia remain unclear.
- Evidence points to dopamine D2 receptor overstimulation and D1 receptor understimulation, alongside altered prefrontal N-methyl aspartate (NMDA) receptor function.
Purpose of the Study:
- To review current knowledge on schizophrenia's neurobiology.
- To focus on the N-methyl aspartate (NMDA) hypofunction hypothesis.
- To explore the interplay between dopamine and glutamate systems in schizophrenia.
Main Methods:
- Review of existing scientific literature.
- Analysis of evidence linking neurotransmitter systems to schizophrenia.
- Discussion of the NMDA hypofunction hypothesis and its implications.
Main Results:
- Schizophrenia involves dysregulation of dopamine D2 and D1 receptors.
- Impaired glutamate transmission at NMDA receptors is a key feature.
- Dopamine imbalances can significantly impact NMDA receptor function.
Conclusions:
- Schizophrenia likely arises from a complex interplay of neurotransmitter aberrations.
- Aberrant dopamine and glutamate transmission are strongly interconnected in schizophrenia.
- The NMDA hypofunction hypothesis offers a significant framework for understanding schizophrenia's neurobiology.
Related Concept Videos
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.5K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.5K
01:28Drug Therapy
449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
449
01:26Psychosis: Goals of Pharmacotherapy
706
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
706
01:28Psychosis and Antipsychotic Drugs: Overview
1.2K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.2K
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:29Biological Causes of Schizophrenia
1.2K
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
1.2K